Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3999603 | Urologic Oncology: Seminars and Original Investigations | 2015 | 7 Pages |
Abstract
In the era of serum prostate-specific antigen testing maturity in conjunction with a single approach to extirpation of the prostate gland by RARP, LVI, MTD, and positive surgical marginsâ¥3 mm are prognostic factors associated with BRFS after RARP. Consideration could be given to incorporate them in the pathology report of the radical prostatectomy specimens and they could assist physicians in clinical decision making.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Sébastien M.D., Benoit M.D., Susanna M.D., Thomas M.D., Eva M.D., Ph.D., Christophe M.D., Pierre M.D., Ph.D., Raphaële M.D., Olivier M.D., Ph.D., Morgan M.D., Ph.D., Sarah J. M.D.,